A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
10/2001
10/25/2001	WO2001079442A2 Albumin fusion proteins
10/25/2001	WO2001079299A1 Enhancement of antibody-mediated immune responses
10/25/2001	WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001	WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001	WO2001079282A2 Molecules associated with human reproduction
10/25/2001	WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	WO2001079271A1 Albumin fusion proteins
10/25/2001	WO2001079258A1 Albumin fusion proteins
10/25/2001	WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001	WO2001078770A1 Inhibition of transmission of tick-borne infections
10/25/2001	WO2001078768A2 Targeted vaccine delivery systems
10/25/2001	WO2001078529A2 Compositions and methods for improving vascular health
10/25/2001	WO2001078511A1 Active substance combinations with insecticidal and acaricidal properties
10/25/2001	WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001	WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001	US20010034331 Isolated polypeptide
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2715554A1 Active substance combinations with insecticidal and acaricidal properties
10/25/2001	CA2406955A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406245A1 Il-174 uses, compositions and methods
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/24/2001	EP1147121A2 Ketolide antibiotics
10/24/2001	EP1146880A2 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway
10/24/2001	CN1319006A Use of organophosphorous compounds for producing medicaments for therapeutic and prophylactic treatment of infections or as fungicide, bactericide or herbicide for plants
10/24/2001	CN1318406A Veterinary liniment containing azedarachin and its preparation
10/24/2001	CN1318405A Veterinary liniment containing azedarine and its preparation
10/24/2001	CN1073437C Chinese medicine for treating digestive tract inflammation and ulcer and its prep.
10/23/2001	US6306896 Pharmaceutically active composition containing artemisinine and/or derivative of artemisinine
10/23/2001	US6306872 6-substituted 1,2,4a,5a,8a,8b-hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6H-pyrrolo[3′,4′:4,5]furo[3,2-b]pyrid-8(7H)-one derivatives and their use in combatting endoparasites
10/23/2001	US6306663 Controlling protein levels in eucaryotic organisms
10/23/2001	US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection
10/23/2001	US6306385 Method of protecting against chronic infections
10/23/2001	CA2096346C Combinations of anthelmintically active agents
10/23/2001	CA2037411C Milbemycin ether derivatives
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
10/18/2001	WO2001076644A2 Lipid-based systems for targeting diagnostic agents
10/18/2001	WO2001076595A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
10/18/2001	WO2001076556A2 Lipid-based drug delivery systems against parasitic infections
10/18/2001	WO2001076555A2 Lipid-based drug delivery systems for topical application
10/18/2001	WO2001076530A2 Il-8 receptor antagonists
10/18/2001	WO2001076370A2 Anthelmintic combinations
10/18/2001	US20010031252 Endogenous immune response
10/18/2001	DE10018370A1 Synergistic pesticidal composition containing phenyl-substituted furanone compound and e.g. chlorfluazuron, emamectin, endosulfan, fibronil or azadirachtin, especially useful as insecticide or acaricide
10/18/2001	DE10014127A1 Antibacterial, fungicidal, antiviral, antiparasitic and herbicidal agents for medicinal, veterinary or agricultural use, comprising amino- or imino-substituted organophosphorus compounds having nitrogen-containing spacer group
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405554A1 Intracorporeal medicaments comprising halogenated xanthenes for high energy phototherapeutic treatment of disease
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2400386A1 Anthelmintic combinations
10/17/2001	EP1146051A2 Erythromycin A derivatives
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1143986A2 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
10/17/2001	EP1143981A1 Treatment and prevention of hiv and other viral infections
10/17/2001	EP1143941A2 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	CN1072960C Medicinal powder for resisting toxoplasmosis
10/17/2001	CN1072933C Albendazole suspension for expelling and controlling parasite in livestock, and prepn. process thereof
10/16/2001	CA2152615C Atovaquone pharmaceutical compositions
10/11/2001	WO2001074899A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis
10/11/2001	WO2001074884A1 Dermacentor variabilis gaba-gated chloride channels
10/11/2001	WO2001074855A2 Compositions and methods for dendritic cell-based immunotherapy
10/11/2001	WO2001074382A1 Method of treatment using ligand-immunogen conjugates
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001024763A3 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/11/2001	US20010029264 In mixture with vitamin e, dimethylisosorbide, citric acid and polyoxyethylene glycol
10/11/2001	US20010029245 Administering a bactericide permeability inducing protein
10/11/2001	DE10015814A1 Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung Medicines to stimulate leukopoiesis, for the treatment of tumors and protozoal diseases and process for its preparation
10/11/2001	CA2405473A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis
10/11/2001	CA2405299A1 Method of treatment using ligand-immunogen conjugates
10/11/2001	CA2403964A1 Compositions and methods for dendritic cell-based immunotherapy
10/10/2001	EP1143004A2 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
10/10/2001	EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001	EP1142577A2 Method of treating a parasitic infection
10/10/2001	EP1141305A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum
10/10/2001	EP1141288A2 Lymphocytic membrane proteins
10/10/2001	EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001	EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001	EP1140992A1 Cyclic peptide antifungal agents having a sugar substituent
10/10/2001	EP1140991A1 Cyclic peptide antifungal agents
10/10/2001	EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001	EP1140152A1 Method to produce inactivated w/o emulsion adjuvated vaccines
10/10/2001	EP1140127A1 Antiprotozoal saponins
10/10/2001	EP1140103A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/10/2001	EP1140102A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/10/2001	EP1140101A1 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/10/2001	EP1140083A1 Novel compounds

1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 218